Showing results (481-490 of 977) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|June 25, 2026
Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriersMartin Widschwendter, Rita Schmutzler, Nora Pashayan, et al.
NPJ Breast Cancer|May 22, 2025
Predicting pathologic ≥N2 disease in women with breast cancerKerollos Nashat Wanis, Wenli Dong, Yu Shen, et al.
NPJ Breast Cancer|August 12, 2026
Genome-wide DNA methylation profiling of triple-negative breast cancer uncovers epigenetic biomarkers of tumor identity and the immune microenvironmentIñaki Sasiain, Deborah F Nacer, Mats Jönsson, et al.
NPJ Breast Cancer|September 19, 2022
MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysisL M Janssen, B M den Dekker, K G A Gilhuijs, et al.
NPJ Breast Cancer|February 13, 2025
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancerRita A Mukhtar, Soumya Gottipati, Christina Yau, et al.
NPJ Breast Cancer|January 22, 2025
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionalityNoor A M Bakker, Hannah Garner, Ewald van Dyk, et al.
NPJ Breast Cancer|January 24, 2025
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypesFresia Pareja, Rohit Bhargava, Virginia F Borges, et al.
NPJ Breast Cancer|November 26, 2024
Palbociclib and letrozole for hormone receptor-positive HER2-negative breast cancer with residual disease after neoadjuvant chemotherapySonia Pernas, Esther Sanfeliu, Guillermo Villacampa, et al.
NPJ Breast Cancer|February 20, 2025
The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtypePolina Turova, Vladimir Kushnarev, Oleg Baranov, et al.
NPJ Breast Cancer|November 7, 2025
Real-world outcomes of trastuzumab deruxtecan in HR-negative HER2-low metastatic breast cancerMengqian Ni, Daining Wang, Shu Dun, et al.
Pageof 98